96955 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Tumour necrosis factor [TNF]
Therapeutic regimen for treating cancer
#602Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders
#603Pharmaceutically acceptable FN3 polypeptides for human treatments
#604Peptides for active anti-cytokine immunization
#605Analytical method and kit thereof
#606Recombinant anti-TNF-α antibodies
#607Methods for treating tweak-related conditions
#608Dominant negative proteins and methods thereof
#609Modified tumor necrosis factor
#610Detoxified TNF and method of preparing
#611DNA 19355 polypeptide, a tumor necrosis factor homolog
#612Virus-like particles for the induction of autoantibodies
#613Albumin fusion proteins
#614Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-α
#615Targeted polypeptides
#616Protein belonging to the TNF superfamily involved in signal transduction and methods of use thereof
#617Homing peptides to receptors of heart vasculature
#61832 human secreted proteins
#619Novel Drosophila tumor necrosis factor class molecule ("DmTNF") and variants thereof
#620Recombinant A2-specific TNFα-specific antibodies
#621Anti-TNF antibody fragments
#622Methods of treating rheumatoid arthritis with anti-TNF antibodies
#623Modified cytokines for use in cancer therapy
#624Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
#625April-a novel protein with growth effects
#626Methods and reagents relating to inflammation and apoptosis
#627Uses of agonists and antagonists to modulate activity of TNF-related molecules
#628Gene transcription and ionizing radiation: methods and compositions
#629Fusion proteins of humanized g250 specific antibodies and uses thereof
#630Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
#631Enhancing the circulating half-life of antibody-based fusion proteins
#632Methods of inhibiting or neutralizing TNFα in patients with tissue injury
#633Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof
#634Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof
#635TNF super family members with altered immunogenicity
#636Method of treating psoriasis using human anti-TNF antibodies and fragments
#637Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
#638Anti-lymphotoxin-β receptor antibodies as anti-tumor agents
#639Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients
#640Modified cytokines for use in cancer therapy
#641Protein based TNF-α variants for the treatment of TNF-α related disorders
#642Ztnf11, a tumor necrosis factor
#643Ztnf12, a tumor necrosis factor
#644Ztnf13, a tumor necrosis factor
#645Selective local activation of members of the TNF receptor family by systemically inactive non-antibody TNF ligand fusion proteins
#646tumor necrosis factor class molecule (“DmTNFv2”)
#647Novel protein and method for producing the protein
#648Albumin fusion proteins comprising GLP-1 polypeptides
#649Antibodies binding the TNF related protein, TNF-Y
#650Novel variants of CD40L protein
#651Chemically modified cytokines
#652Treatment of TNF-α related disorders with TNF-α variant proteins
#653Heteromultimeric TNF ligand family members
#654Nucleic acids encoding multimeric proteins of TNF superfamily ligands
#655BAFF variants and methods thereof
#656Modified peptides as therapeutic agents
#657Methods for rational pegylation of proteins
#658APRIL-A novel protein with growth effect
#659Methods of treating carcinoma using anti-TNF antibodies and peptides
#660Fusions of cytokines and tumor targeting proteins
#661BAFF variants and methods thereof
#662Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
#663Protein scaffolds for antibody mimics and other binding proteins
#664Methods of inhibiting TNFα in patients with cancer
#665Immunoconjugates for the treatment of tumours
#666Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
#667Increased T-cell tumor infiltration by mutant LIGHT
#668Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
#669Physiologically active complex
#670April variants and methods thereof
#671Antibodies to OCIF-binding molecules
#672Monoclonal blocking antibody to human RANKL
#673Anti-quorum and DNA cleaving agent
#674Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines)